华熙生物预计2025年净利润同比增加54.93%—83.63%

Core Viewpoint - Huaxi Bio announced its 2025 performance forecast, expecting a significant increase in net profit attributable to shareholders, indicating strong growth potential for the company [1] Financial Performance - The company anticipates a net profit attributable to shareholders of 270 million to 320 million yuan for 2025, representing a year-on-year increase of 54.93% to 83.63% [1] - The expected net profit, excluding non-recurring gains and losses, is projected to be between 167 million and 217 million yuan, with a year-on-year growth of 55.68% to 102.29% [1]